Skip to main content
High RiskFDAfda-H-0521-2026E COLI

Aonic Complete His. Dosage: Single serving liquid dietary supplement drink shot, 34 ml (1.1 Fl oz) in plastic bottle, induction sealed cl...

Category
Units Affected
780
Recall Date
January 15, 2026
Issuing Agency
Hazard
E Coli

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0521-2026.

Possible coliforms, E.coli, and/or Pseudomonas aeruginosa contamination.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0521-2026.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Tks Co-pack Manufacturing, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0521-2026.

TKS Co-pack Manufacturing, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Tks Co-pack Manufacturing, Llc Recall FAQ

Tks Co-pack Manufacturing, Llc is the subject of a beverages safety report: Aonic Complete His. Dosage: Single serving liquid dietary supplement drink shot, 34 ml (1.1 Fl oz) in plastic bottle, induction sealed cl.... The notice was published on January 15, 2026 by the U.S. Food and Drug Administration (FDA). Approximately 780 units are potentially affected.